Global Retirement Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.2K | Buy |
+151
| New | +$49.2K | ﹤0.01% | 1781 |
|
|
2024
Q4 | $19.1K | Sell |
81
-20
| -20% | -$4.71K | ﹤0.01% | 2115 |
|
|
2024
Q3 | $27.8K | Buy |
101
+48
| +91% | +$13.2K | ﹤0.01% | 1835 |
|
|
2024
Q2 | $12.9K | Sell |
53
-10
| -16% | -$2.43K | ﹤0.01% | 2201 |
|
|
2024
Q1 | $9.42K | Sell |
63
-15
| -19% | -$2.24K | ﹤0.01% | 2153 |
|
|
2023
Q4 | $14.6K | Sell |
78
-12
| -13% | -$2.25K | ﹤0.01% | 1906 |
|
|
2023
Q3 | $15.2K | Buy |
90
+5
| +6% | +$846 | ﹤0.01% | 1772 |
|
|
2023
Q2 | $16.1K | Hold |
85
| – | – | ﹤0.01% | 1760 |
|
|
2023
Q1 | $17K | Buy |
85
+8
| +10% | +$1.6K | ﹤0.01% | 1707 |
|
|
2022
Q4 | $18.3K | Sell |
77
-4
| -5% | -$951 | ﹤0.01% | 1521 |
|
|
2022
Q3 | $17K | Sell |
81
-5,179
| -98% | -$1.09M | ﹤0.01% | 1458 |
|
|
2022
Q2 | $767K | Buy |
5,260
+47
| +0.9% | +$6.85K | 0.06% | 281 |
|
|
2022
Q1 | $662K | Buy |
+5,213
| New | +$662K | 0.05% | 313 |
|
|
2021
Q4 | – | Sell |
-2,034
| Closed | -$384K | – | 304 |
|
|
2021
Q3 | $384K | Buy |
2,034
+62
| +3% | +$11.7K | 0.04% | 344 |
|
|
2021
Q2 | $334K | Buy |
1,972
+160
| +9% | +$27.1K | 0.03% | 362 |
|
|
2021
Q1 | $256K | Buy |
1,812
+1,728
| +2,057% | +$244K | 0.03% | 374 |
|
|
2020
Q4 | $11K | Hold |
84
| – | – | ﹤0.01% | 1217 |
|
|
2020
Q3 | $12K | Hold |
84
| – | – | ﹤0.01% | 1077 |
|
|
2020
Q2 | $12K | Buy |
84
+4
| +5% | +$571 | ﹤0.01% | 1056 |
|
|
2020
Q1 | $9K | Hold |
80
| – | – | ﹤0.01% | 1047 |
|
|
2019
Q4 | $9K | Hold |
80
| – | – | ﹤0.01% | 1165 |
|
|
2019
Q3 | $6K | Hold |
80
| – | – | ﹤0.01% | 1232 |
|
|
2019
Q2 | $6K | Buy |
+80
| New | +$6K | ﹤0.01% | 1227 |
|